SLC5A2 and coronary artery disorder: The incidence and severity of CHD can be reduced via the application of SGLT2 inhibitors in which the SGLT2 can decrease the autosis of cardiac cell and the subsequent myocardial infarction episode in the experimental model 7, 20.